{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:45:50Z","timestamp":1782017150088,"version":"3.54.5"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1182032"],"award-info":[{"award-number":["OPP1182032"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Nontyphoidal Salmonella and Salmonella Paratyphi are responsible for significant morbidity and mortality worldwide. To date, no vaccine has been licensed against these organisms. The development of effective vaccines remains an urgent priority. In this review, the rationale for and current status of various vaccine candidates against S. Paratyphi and nontyphoidal Salmonella are presented, with a focus on the research findings from the 2019 International Conference on Typhoid and Other Invasive Salmonelloses. Additionally, other vaccine candidates that are currently undergoing clinical development are highlighted. Future approaches, which may include antigens that are genetically conserved across Salmonella and confer broad, non\u2013serotype-specific protection, are also discussed.<\/jats:p>","DOI":"10.1093\/cid\/ciaa514","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T19:14:10Z","timestamp":1588101250000},"page":"S151-S154","source":"Crossref","is-referenced-by-count":57,"title":["Overview of the Nontyphoidal and Paratyphoidal Salmonella Vaccine Pipeline: Current Status and Future Prospects"],"prefix":"10.1093","volume":"71","author":[{"given":"Scott M","family":"Baliban","sequence":"first","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland, School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jie","family":"Lu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"2020073002271793900_CIT0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"Typhoid GBD, Paratyphoid C. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the global burden of disease study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020073002271793900_CIT0002","doi-asserted-by":"crossref","first-page":"e0005118","DOI":"10.1371\/journal.pntd.0005118","article-title":"A systematic review of the incidence, risk factors and case fatality rates of invasive nontyphoidal Salmonella (iNTS) disease in Africa (1966 to 2014)","volume":"11","author":"Uche","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002271793900_CIT0003","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2020073002271793900_CIT0004","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijmm.2015.07.004","article-title":"Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate","volume":"305","author":"Xiong","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"2020073002271793900_CIT0005","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.vaccine.2010.03.019","article-title":"Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates","volume":"28","author":"Roland","year":"2010","journal-title":"Vaccine"},{"key":"2020073002271793900_CIT0006","doi-asserted-by":"crossref","first-page":"e1373","DOI":"10.1371\/journal.pntd.0001373","article-title":"Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines","volume":"5","author":"Gat","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002271793900_CIT0007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2019.03.003","article-title":"Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902","volume":"201","author":"Wahid","year":"2019","journal-title":"Clin Immunol"},{"key":"2020073002271793900_CIT0008","first-page":"e00474","article-title":"Improving","volume":"3(6)","author":"Higginson","year":"2018;","journal-title":"mSphere"},{"key":"2020073002271793900_CIT0009","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1128\/IAI.05278-11","article-title":"Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains","volume":"79","author":"Tennant","year":"2011","journal-title":"Infect Immun"},{"key":"2020073002271793900_CIT0010","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/hv.29054","article-title":"Vaccines against invasive Salmonella disease: current status and future directions","volume":"10","author":"MacLennan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"2020073002271793900_CIT0011","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.vaccine.2016.03.072","article-title":"Nontyphoidal Salmonella disease: current status of vaccine research and development","volume":"34","author":"Tennant","year":"2016","journal-title":"Vaccine"},{"key":"2020073002271793900_CIT0012","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.68.4.2135-2141.2000","article-title":"Pilot study of phoP\/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers","volume":"68","author":"Angelakopoulos","year":"2000","journal-title":"Infect Immun"},{"key":"2020073002271793900_CIT0013","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"key":"2020073002271793900_CIT0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2014.07.005","article-title":"A scalable method for biochemical purification of Salmonella flagellin","volume":"102","author":"Simon","year":"2014","journal-title":"Protein Expr Purif"},{"key":"2020073002271793900_CIT0015","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/IAI.05484-11","article-title":"Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis","volume":"79","author":"Simon","year":"2011","journal-title":"Infect Immun"},{"key":"2020073002271793900_CIT0016","doi-asserted-by":"crossref","first-page":"e0005493","DOI":"10.1371\/journal.pntd.0005493","article-title":"Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa","volume":"11","author":"Baliban","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002271793900_CIT0017","doi-asserted-by":"crossref","first-page":"e0006522","DOI":"10.1371\/journal.pntd.0006522","article-title":"Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice","volume":"12","author":"Baliban","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002271793900_CIT0018","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071749","article-title":"Immunogenicity and induction of functional antibodies in rabbits immunized with a trivalent typhoid-invasive nontyphoidal salmonella glycoconjugate formulation","volume":"23","author":"Baliban","year":"2018","journal-title":"Molecules"},{"key":"2020073002271793900_CIT0019","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/IAI.68.3.1529-1534.2000","article-title":"Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"68","author":"Konadu","year":"2000","journal-title":"Infect Immun"},{"key":"2020073002271793900_CIT0020","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2016.03.106","article-title":"Status of paratyphoid fever vaccine research and development","volume":"34","author":"Martin","year":"2016","journal-title":"Vaccine"},{"key":"2020073002271793900_CIT0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41541-017-0037-1","article-title":"Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo","volume":"3","author":"Sun","year":"2018","journal-title":"NPJ Vaccines"},{"key":"2020073002271793900_CIT0022","doi-asserted-by":"crossref","first-page":"13564","DOI":"10.1073\/pnas.1307228110","article-title":"Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020073002271793900_CIT0023","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.chom.2014.05.009","article-title":"The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design","volume":"15","author":"van Sorge","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2020073002271793900_CIT0024","first-page":"e01949","article-title":"Protection against Staphylococcus aureus colonization and infection by B- and T-cell-mediated mec","volume":"9. pii:","author":"Zhang","year":"2018","journal-title":"MBio"},{"key":"2020073002271793900_CIT0025","article-title":"Development of a MAPS-Based Typhoid and Paratyphoid A Vaccine. In: 2019 International Conference on Typhoid and Other Invasive Salmonelloses","author":"Lu","journal-title":"Hanoi, Vietnam:"},{"key":"2020073002271793900_CIT0026","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jbiotec.2015.01.020","article-title":"Simplified low-cost production of O-antigen from Salmonella Typhimurium Generalized Modules for Membrane Antigens (GMMA)","volume":"198","author":"Meloni","year":"2015","journal-title":"J Biotechnol"},{"key":"2020073002271793900_CIT0027","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/CVI.00023-16","article-title":"Toll-like receptor activation by generalized modules for membrane antigens from lipid a mutants of Salmonella enterica serovars typhimurium and enteritidis","volume":"23","author":"Rossi","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"2020073002271793900_CIT0028","article-title":"Development of a vaccine based on GMMA against invasive non-typhoidal Salmonella disease: Towards phase 1 testing in humans. In: 2019 International Conference on Typhoid and Other Invasive Salmonelloses","author":"Koeberling","journal-title":"Hanoi, Vietnam:"},{"key":"2020073002271793900_CIT0029","article-title":"Local and systemic immune response to a vaccine against Salmonella Typhimurium based on generalized modules for membrane antigens (GMMA). In: 2019 International Conference on Typhoid and Other Invasive Salmonelloses","author":"Fiorino","journal-title":"Hanoi, Vietnam:"},{"key":"2020073002271793900_CIT0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1128\/CVI.00243-16","article-title":"Salmonella serogroup C: current status of vaccines and why they are needed","volume":"23","author":"Fuche","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"2020073002271793900_CIT0031","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4269\/ajtmh.17-0508","article-title":"Characterization of invasive salmonella serogroup C1 infections in mali","volume":"98","author":"Fuche","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020073002271793900_CIT0032","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.4049\/jimmunol.178.10.6200","article-title":"Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection","volume":"178","author":"Cunningham","year":"2007","journal-title":"J Immunol"},{"key":"2020073002271793900_CIT0033","doi-asserted-by":"crossref","first-page":"9803","DOI":"10.1073\/pnas.0812431106","article-title":"The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response","volume":"106","author":"Gil-Cruz","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020073002271793900_CIT0034","doi-asserted-by":"crossref","first-page":"13462","DOI":"10.1073\/pnas.1606290113","article-title":"Siderophore-based immunization strategy to inhibit growth of enteric pathogens","volume":"113","author":"Sassone-Corsi","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020073002271793900_CIT0035","doi-asserted-by":"crossref","first-page":"e0005207","DOI":"10.1371\/journal.pntd.0005207","article-title":"Role of T3SS-1 SipD protein in protecting mice against non-typhoidal Salmonella Typhimurium","volume":"10","author":"Jneid","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002271793900_CIT0036","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.1601357","article-title":"Dual immunization with SseB\/flagellin provides enhanced protection against salmonella infection mediated by circulating memory cells","volume":"199","author":"Lee","year":"2017","journal-title":"J Immunol"},{"key":"2020073002271793900_CIT0037","doi-asserted-by":"crossref","first-page":"e00473","DOI":"10.1128\/IAI.00473-17","article-title":"Characterization and protective efficacy of type III secretion proteins as a broadly protective subunit vaccine against salmonella enterica serotypes","volume":"86","author":"Martinez-Becerra","year":"2018","journal-title":"Infect Immun"},{"key":"2020073002271793900_CIT0038","doi-asserted-by":"crossref","first-page":"34776","DOI":"10.1038\/srep34776","article-title":"Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2020073002271793900_CIT0039","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijmm.2016.08.004","article-title":"Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model","volume":"306","author":"Liu","year":"2016","journal-title":"Int J Med Microbiol"},{"key":"2020073002271793900_CIT0040","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/21505594.2018.1559673","article-title":"Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains","volume":"10","author":"Liu","year":"2019","journal-title":"Virulence"},{"key":"2020073002271793900_CIT0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-017-0041-5","article-title":"Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated Salmonella Typhimurium induce strong immune responses against these two antigens","volume":"3","author":"Li","year":"2018","journal-title":"NPJ Vaccines"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_2\/S151\/33546470\/ciaa514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_2\/S151\/33546470\/ciaa514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T06:27:59Z","timestamp":1596090479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/Supplement_2\/S151\/5877830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":41,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2020,7,29]]},"published-print":{"date-parts":[[2020,7,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa514","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,15]]},"published":{"date-parts":[[2020,7,29]]}}}